top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Animal Modeling in Cancer
Animal Modeling in Cancer
Autore Korinek Vladimir
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (273 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato soy
isoflavones
mammary tumor prevention
rodent models
chemical carcinogens
transgenic mice
Zebrafish
Drosophila
rats
mice
NPM-1
FLT3 ITD
ETO-1
IDH1/2
neural stem cells
brain and nervous system cancers
neurogenic niches
radiotherapy
sparing of neurogenic regions
carcinoma
consensus molecular subtypes
intestine
oncogenes
signaling cascades
tumor suppressors
tumorigenesis
MPN (myeloproliferative neoplasms)
zebrafish
iPSCs
JAK2
MPL
CALR
thrombosis
ubiquitin–proteasome system
cancer
mouse model
gene inactivation
colorectal cancer
mouse models
microbiota
antitumor immunity
melanoma
mutation
genetics
animal model
swine
MeLiM
progression
spontaneous regression
devitalization
metaplasia
Cdx
animal models
epigenetics
xenotransplantation
drug screen
pre-clinical cancer model
non-mouse models
gene editing
stem cells
solid tumors
hematologic malignancies
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557344403321
Korinek Vladimir  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer Drugs
Anticancer Drugs
Autore O’Boyle Niamh M
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (214 p.)
Soggetto non controllato graphene oxide
indole
androgens
cyclooxygenase-2
cyclooxygenase-1
heteropolysaccharide
drug conjugation
drug delivery
ellipticine
chemical linker
oesophageal cancer
antiproliferative activity
topoisomerase II
?-lactam
DSD
antibody
topoisomerase inhibitors
magnetic targeting
cisplatin resistance
steroidogenesis
[18F]FDG PET/CT
heterocyclic chemistry
dehydroepiandrosterone
antimitotic
3-vinylazetidin-2-ones
glioblastoma
and cancer therapy
intestinal mucositis
Combretastatin A-4
metabolism
anti-cancer drugs
maghemite
COX-1 inhibitor
anticancer
CYP17A1
conjugate and hybrid drugs
inflammation
snticancer drugs
P450c17
tumorigenesis
cisplatin
biomarker profiling
cancer drug design
tubulin
cytochrome P450
5-fluorouracil
prostate cancer
abiraterone
NCI screen
radiation
cancer immunotherapy
microtubule targeted drugs
cancer
treatment resistance
ISBN 3-03921-587-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367753903321
O’Boyle Niamh M  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Anticancer Inhibitors
Anticancer Inhibitors
Autore Fantacuzzi Marialuigia
Pubbl/distr/stampa Basel, : MDPI Books, 2022
Descrizione fisica 1 electronic resource (216 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato breast cancer
tamoxifen
LY294002
synergism
apoptosis
cell cycle
tea (Camellia sinensis) flowers
BTFS
A2780/CP70 ovarian cancer cells
S phase cell cycle arrest
nicotinamide phosphoribosyltransferase
NAD+ biosynthesis
inhibitor
azacyclohexane
anticancer drug
drug design
enthalpy effect
NSCLC
Cathepsin K
cell proliferation
cell migration
cell invasion
mTOR
isatin-hydrazones
cytotoxicity
CDK2 inhibitor
ATP competitive inhibitor
ADME analysis
receptor tyrosine kinases
protein-protein interactions
protein engineering
directed evolution
angiogenesis
binding affinity
agonistic activity
saponins
phytochemicals
tea (Camellia sinensis) flower
ovarian cancer
autophagy
ZMYND8
tumorigenesis
epigenetic regulation
pro-oncogenic effects
tumor suppression
tacrine-coumarin derivatives
DNA
topoisomerases I, II
lung carcinoma cells
A549
chemotherapy
prodrug
drug targeting
overexpressed enzymes
ADC
ADEPT
GDEPT
LEAPT
PROTAC
cyclin-dependent kinase
cancer
resistance
small molecule inhibitors
PROTACs
statins
pancreatic cancer
DNA microarray
pitavastatin
cerivastatin
simvastatin
fluvastatin
atorvastatin
pravastatin
HMG-CoA reductase inhibitors
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910595069203321
Fantacuzzi Marialuigia  
Basel, : MDPI Books, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Apoptotic Cell Clearance in Health and Disease
Apoptotic Cell Clearance in Health and Disease
Autore Amiram Ariel
Pubbl/distr/stampa Frontiers Media SA, 2018
Descrizione fisica 1 electronic resource (294 p.)
Collana Frontiers Research Topics
Soggetto non controllato Phagocytes
immune-regulation
development
Efferocytosis
Homeostasis
neurodegeneration
tumorigenesis
Apoptosis
receptor-ligand interactions
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910346757403321
Amiram Ariel  
Frontiers Media SA, 2018
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
Biomarkers for Diagnosis, Complications and Therapy Effects in Civilization Diseases Management
Autore Komosinska-Vassev Katarzyna
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (208 p.)
Soggetto topico Medicine
Soggetto non controllato pharmacogenomics
NGS variants
personalized medicine
FSHR
personalized drug therapy
hedgehog-interacting protein
impaired fasting glucose
impaired glucose tolerance
newly diagnosed diabetes
normal glucose tolerance
inflammatory bowel disease
ulcerative colitis
Crohn’s disease
extracellular matrix components
hyaluronan
inflammatory bowel diseases (IBD)
Crohn’s disease (CD)
ulcerative colitis (UC)
sulfated glycosaminoglycans (sGAG)
hyaluronan (HA)
soluble part of syndecan-1 (sCD138)
microRNA
cardiovascular disease
diabetes
mortality
antiplatelet therapy
platelet reactivity
Let-7e
miR-126
miR-223
miR-125a-3p
CCL11
CCL24
CCL26
CCR3
CRC
adiponectin
adipokines
rheumatology
obesity
overweight
case control study
rheumatoid arthritis
TNF-α inhibitors
bone turnover markers
PINP
PICP
NTX-I
CTX-I
RANKL/OPG
ovarian cancer
interleukin 21
interleukin 22
lymphocytes
macrophages
dendritic cells
innate lymphoid cells
breast cancer
extracellular matrix
proteins
tumorigenesis
tumor microenvironment
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566458203321
Komosinska-Vassev Katarzyna  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Autore Ecke Thorsten
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (240 p.)
Soggetto topico Medicine
Soggetto non controllato Metallothionein
urothelium
urothelial cancer
cadmium exposure
zinc transporter
bladder
TAGLN
F-actin
PTEN
p53
tumorigenesis
proliferation
invasion
TERT promoter mutations
FGFR3
non muscle invasive bladder cancer
BCG therapy
bladder cancer
JAK-STAT pathway
combination therapy
oncolytic adenovirus
virotherapy
STAT3/5 inhibitor
JAK inhibitor
XVir-N-31
bladder cancer detection
urinary biomarkers
DNA methylation
ECRG4
ITIH5
biomarker
cancer
grade
metabolomics
MS
NMR
biomarkers
tumor markers
prognosis
heparanase
syndecan-1
heparan sulfate proteoglycans (HSPGs)
urothelial carcinoma
miRNA
quantitative PCR
tumor marker
voided urine cytology
KDM7A
histone demethylase
TC-E 5002
androgen receptor
drug resistance
non-invasive detection
telomerase
somatic mutations
TERT promoter region
muscle-invasive bladder cancer
chemotherapy
immunotherapy
personalized medicine
predictive biomarker
survivin
BIRC5
macrophage
KRT20
ERBB2
MIBC
prediction
RT-qPCR
adjuvant chemotherapy
survival
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557142003321
Ecke Thorsten  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Disease and the Hippo Pathway: Cellular and Molecular Mechanisms
Disease and the Hippo Pathway: Cellular and Molecular Mechanisms
Autore Hansen Carsten Gram
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (226 p.)
Soggetto non controllato STRIPAK
skin cancer
Lats2
transcription
myofibroblast
epigenetic
Hippo
cancer immunity
TAZ
Taz
TAZ (transcriptional co-activator with PDZ-binding motif)
adaptive immunity
fibroblasts
innate immunity
LATS
MST (mammalian STE20-like protein kinase)
phosphorylation
stem cells
wound healing
signal transduction
angiogenesis
LATS1/2
EMT
protein-protein interactions
structure biology
Hippo pathway
hippo pathway
autoimmunity
Mps one binder
YAP/TAZ
GPCR
fibrosis
MST1/2
YAP (yes-associated protein)
YAP
Yap
protein kinase
LATS (large tumor suppressor kinase)
peripheral nerve sheath tumor
signal cross-talk
stem cell
skin development
STK38
tumorigenesis
NDR
schwannoma
G protein-coupled receptor
anti-cancer therapy
feedback loops
vascular mimicry
castration resistance
chromatin
Hippo signalling
ECM
MST
prostate cancer
TEAD
cancer
zebrafish
ISBN 3-03921-777-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Disease and the Hippo Pathway
Record Nr. UNINA-9910367742003321
Hansen Carsten Gram  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Head and Neck Critical Illness : Basic and Clinical Research Implications
Head and Neck Critical Illness : Basic and Clinical Research Implications
Autore Tomita Hiroyuki
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (258 p.)
Soggetto topico Medicine
Soggetto non controllato BDNF
Brain-Derived Neurotrophic Factor
navigation
spatial processing
trauma
trauma processing
Post-Traumatic Stress Disorder
PSTD
allocentric
hippocampus
sinonasal tract
malignant tumor
CT
MRI
neuropsychiatric presentation of encephalitis
paraneoplastic encephalitis
autoimmune encephalitis
infectious encephalitis
diffuse large B-cell lymphoma
canaloplasty
non-perforating surgical procedures
corticosteroid-induced glaucoma
Schlemm’s canal
neck mass
diffusion-weighted MRI
apparent diffusion coefficient
procalcitonin
bacterial meningitis
viral meningitis
antibiotic therapy
biomarker
differential diagnosis
human papillomavirus
human cancer
head and neck
reduction therapy
head and neck squamous cell carcinoma (HNSCC)
neutrophil-to-lymphocyte ratio (NLR)
myeloid-derived suppressor cells (MDSC)
aldehyde dehydrogenase 1 (ALDH1)
prognosis
prodigiosin
doxorubicin
priming
influx
autophagy
cervical
cellulitis
abscess
deep neck infection
diabetes mellitus
MAP1LC3B
SQSTM1
subsites
tumorigenesis
oral cancer
Nox4
oral tongue cancer
squamous cell carcinoma
surgery
head and neck squamous cell carcinoma
HPV
11q13
gene amplification
immunohistochemistry
head and neck cancer
radiotherapy
neutrophil/lymphocyte ratio
survival
ZFAND4
ANUBL1
oral squamous cell carcinoma
nucleotide excision repair
genetic polymorphism
concurrent chemoradiotherapy
HNSCC
MIF
4-IPP
metabolism
annexin A9
annexin A10
differentiation grade
NGS
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Head and Neck Critical Illness
Record Nr. UNINA-9910557535203321
Tomita Hiroyuki  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Physiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment
Physiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment
Autore Di Meo Sergio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (236 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato CTCL
apoptosis
cell viability
c-FLIP
XIAP
artemisinin
SH-SY5Y cells
hippocampal neurons
H2O2
AMPK pathway
atherosclerosis
sphingomyelin synthase 2
endothelial dysfunction
endoplasmic reticulum stress
β-catenin
insulin resistance
cancer
cardiovascular disease
neurodegenerative disorders
exercise
mitochondria
oxidative stress
PGC-1
Nrf2
UCPs
ROS
light
DNA damage
evolution
D-box
cavefish
Spalax
trimethylamine N-oxide
cardiomyocytes
cardiotoxicity
mitochondrial membrane potential
CORM-2
NADPH oxidase
AP-1
HO-1
Renal cell carcinoma (RCC)
reactive oxygen species (ROS)
glutathione (GSH) metabolism
cancer therapy
clear cell RCC
papillary RCC
chromophobe RCC
sarcopenia
reactive oxygen species
redox signaling
antioxidant supplementation
protein aggregation
redox
proteinopathy
peroxiredoxins
tumorigenesis
ROS scavengers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Physiological and Pathological Role of ROS
Record Nr. UNINA-9910557430503321
Di Meo Sergio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Targeting STAT3 and STAT5 in Cancer
Targeting STAT3 and STAT5 in Cancer
Autore Moriggl Richard
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (578 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato multiple myeloma
STAT3
S3I-1757
nanoparticle
CD38
siRNA/RNAi
polyethylenimine
PEI
lipopolyplex
siRNA delivery
glioma
glioblastoma
STAT5
AKT
ERK1/2
prolactin
androgens
prostate cancer
knockout
escape mechanisms
stem/progenitor cells
cell hierarchy
cancer
CD4+ T cells
CD8+ T cells
myeloid cells
immune check point
hepatitis C virus (HCV)
cirrhosis
hepatocellular carcinoma (HCC)
endoplasmic reticulum (ER) stress
oxidative stress (OS)
unfolded protein response (UPR)
microRNA-122 (miR-122)
nuclear factor erythroid 2-related factor 2 (NRF2)
signal transducer and activator of transcription 3 (STAT3)
hepatocyte nuclear factor 4 alpha (HNF4A)
solid cancers
cell cycle
apoptosis
inflammation
mitochondria
stemness
tumor suppression
melanoma
autoimmune disease
immunotherapy
tumor-immune cell interactions
breast cancer
PD-L1
M2 macrophages
NK cells
STAT3 inhibitor XIII
hedging
transaction costs
dynamic programming
risk management
post-decision state variable
cancer progression
cancer-stem cell
cytokine
therapy resistance
metastasis
immunosuppression
tumor microenvironment
proliferation
tyrosine kinase 2
JAK family of protein tyrosine kinases
signal transducer and activator of transcription
cytokine receptor signaling
gain-of-function mutation
tumorigenesis
ADAM17
interleukin-6
trans-signaling
epidermal growth factor receptor (EGF-R)
shedding
metalloprotease
tumor necrosis factor alpha (TNFα)
inflammation associated cancer
colon cancer
lung cancer
SH2 domain
mutations
autosomal-dominant hyper IgE syndrome
inflammatory hepatocellular adenomas
T-cell large granular lymphocytic leukemia
T-cell prolymphocytic leukemia
growth hormone insensitivity syndrome
nuclear pore complex
nuclear transport receptors
nucleocytoplasmic shuttling
targeting
tumor-associated macrophages
adoptive T cell therapy
immune suppression
STAT transcription factors
JAK
STAT
T-PLL
T-cell leukemia
meta-analysis
STAT5B signaling
small-molecule inhibitors
cancer models
companion animals
comparative oncology
pharmacological inhibitor
STAT5 signaling
chemotherapy resistance
myeloid leukemia
heat shock proteins
chaperones
stabilization
targeted therapy
ovarian cancer
hematopoietic cancers
therapeutic targeting
pharmacological inhibitors
mTOR
Bone Marrow Failure Syndromes
lymphocytes
lymphoma
T-cells
RHOA
NGS
MPN
JAK2 V617F
neoplastic stem cells
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557623503321
Moriggl Richard  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui